BOOK-CHAPTER
DAUNOrubicin and Cytarabine, Liposome
Stephanie J. PhelpsTracy M. HagemannKelley R. Lee
Year: 2024 ASHP eBooks Pages: 357-360
Keywords:
Daunorubicin Cytarabine Liposome Medicine Pharmacology Internal medicine Chemistry Leukemia Biochemistry
Metrics
0
Cited By
0.00
FWCI (Field Weighted Citation Impact)
0
Refs
0.51
Citation Normalized Percentile
Is in top 1%
Is in top 10%
Topics
Cancer Treatment and Pharmacology
Health Sciences → Medicine → Oncology
Fungal Infections and Studies
Health Sciences → Medicine → Epidemiology
Related Documents
JOURNAL ARTICLE
Daunorubicin and Cytarabine Liposome (Vyxeos)
Journal: Canadian Journal of Health Technologies Year: 2021 Vol: 1 (10)
JOURNAL ARTICLE
Daunorubicin & Cytarabine Liposome (Vyxeos™)
Journal: Oncology Times Year: 2018 Vol: 40 (10)Pages: 30-30
JOURNAL ARTICLE
Daunorubicin see Cytarabine/daunorubicin
Journal: Reactions Weekly Year: 1991 Vol: &NA; (354)Pages: 8-8
JOURNAL ARTICLE
Cytarabine/cytarabine/daunorubicin/etoposide
Journal: Reactions Weekly Year: 2022 Vol: 1917 (1)Pages: 201-201
JOURNAL ARTICLE
Cytarabine/daunorubicin
Journal: Reactions Weekly Year: 2022 Vol: 1926 (1)Pages: 192-192